Login / Signup

Real-life study in non-atopic severe asthma patients achieving disease control by omalizumab treatment.

Paloma CampoGregorio Soto CamposAna MoreiraSantiago QuirceAlicia Padilla-GaloEva Martínez-MoragónAizea MardonesIgnacio Dávila
Published in: Allergy (2020)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • peritoneal dialysis
  • combination therapy